| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024911993 |
| P356 | DOI | 10.1038/SJ.BMT.1704892 |
| P698 | PubMed publication ID | 15765114 |
| P50 | author | Ina Kötter | Q19859604 |
| Jakob R. Passweg | Q67905482 | ||
| Nico M Wulffraat | Q90281741 | ||
| Dominique Farge | Q90288809 | ||
| P2093 | author name string | J Moore | |
| B Löwenberg | |||
| A Fassas | |||
| R Saccardi | |||
| J A Snowden | |||
| A Gratwohl | |||
| A Marmont | |||
| A Tyndall | |||
| C Bocelli-Tyndall | |||
| F van den Hoogen | |||
| J Finke | |||
| J M van Laar | |||
| R Arnold | |||
| I Lisukov | |||
| E Carreras | |||
| T Kozak | |||
| X W Zhao | |||
| M Andolina | |||
| Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT) | |||
| P2860 | cites work | Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. | Q44814824 |
| Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring | Q46214595 | ||
| Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor | Q47590532 | ||
| Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. | Q54104613 | ||
| Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study | Q58416201 | ||
| Prolonged remission state of refractory adult onset Still's disease following CD34-selected autologous peripheral blood stem cell transplantation | Q60671969 | ||
| Haemopoietic stem-cell transplantation for juvenile chronic arthritis | Q61831539 | ||
| Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients | Q70994779 | ||
| Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation | Q73028037 | ||
| High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis | Q73045390 | ||
| High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial | Q73183259 | ||
| Autologous peripheral blood stem cell transplantation in a patient with severe mixed connective tissue disease | Q73229339 | ||
| Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus | Q73661514 | ||
| High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy | Q73792142 | ||
| Autologous stem cell transplantation for rapidly progressive Jo-1-positive polymyositis with long-term follow-up | Q73942374 | ||
| Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis | Q77318072 | ||
| Stem cell transplantation for autoimmune diseases | Q77850793 | ||
| A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis | Q78301146 | ||
| Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? | Q78512358 | ||
| Autologous stem cell transplantation for systemic lupus erythematosus | Q80031296 | ||
| Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells | Q24792552 | ||
| High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia | Q33344858 | ||
| Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. | Q33361139 | ||
| Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease | Q34109010 | ||
| Treatment of autoimmune diseases by hematopoietic stem cell transplantation | Q34264891 | ||
| Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma | Q34288599 | ||
| Autoimmune diseases. | Q34325674 | ||
| Autologous stem cell transplantation in the treatment of refractory rheumatoid arthritis | Q34657937 | ||
| Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review | Q35071105 | ||
| Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. | Q35204115 | ||
| Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease | Q35550480 | ||
| Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry | Q35554404 | ||
| Hematopoietic cell transplantation for benign hematological disorders and solid tumors. | Q35591460 | ||
| Stem cell transplantation for autoimmune disorders. Preclinical experiments | Q35859396 | ||
| Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications | Q35859399 | ||
| High-dose immunosuppressive therapy and autologous progenitor cell transplantation for systemic sclerosis | Q35859402 | ||
| Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy | Q40621963 | ||
| High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. | Q40625080 | ||
| Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. | Q40637757 | ||
| Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases | Q41472770 | ||
| Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue | Q43561533 | ||
| Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. | Q43668453 | ||
| Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients | Q44213845 | ||
| High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus | Q44278522 | ||
| Single versus double autologous stem-cell transplantation for multiple myeloma. | Q44706045 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stem cell transplantation | Q65592366 |
| P304 | page(s) | 869-879 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Autologous hematopoietic stem cell transplantation for autoimmune diseases | |
| P478 | volume | 35 |
| Q37454367 | ANCA-associated vasculitis: from bench research to novel treatments |
| Q92107004 | Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties |
| Q79761733 | Allogeneic haematopoietic stem cell transplantation for severe autoimmune diseases: great expectations but controversial evidence |
| Q30382499 | An Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood. |
| Q35153218 | Angiomyeloproliferative lesions following autologous stem cell therapy |
| Q34110184 | Angiopoietin-like protein 3 promotes preservation of stemness during ex vivo expansion of murine hematopoietic stem cells |
| Q37987428 | Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases |
| Q63214358 | Autologe Stammzelltransplantation bei systemischer Sklerose |
| Q37195389 | Autologous haematopoietic stem-cell transplantation in multiple sclerosis |
| Q33632260 | Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. |
| Q37810087 | Autologous hematopoietic stem cell transplantation in autoimmune diseases |
| Q31075436 | Autologous hematopoietic stem cell transplantation in multiple sclerosis: 20 years of experience. |
| Q40545323 | Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus |
| Q26853376 | Bone marrow transplantation for Behçet's disease: a case report and systematic review of the literature |
| Q35868954 | Cell therapy for autoimmune diseases |
| Q37220543 | Cellular therapy of systemic sclerosis |
| Q44580937 | Current value of stem-cell transplantation in autoimmune diseases |
| Q37246074 | Early recovery of CD4 T cell receptor diversity after "lymphoablative" conditioning and autologous CD34 cell transplantation |
| Q40041536 | Feasibility and toxicity of hematopoietic stem cell transplant in multiple sclerosis. |
| Q36020897 | Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation |
| Q34551863 | Haematopoietic stem cell transplantation for autoimmune diseases |
| Q35638755 | Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a r |
| Q36164087 | Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions |
| Q36252940 | Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States |
| Q26751425 | Hematopoietic stem cell transplantation for auto immune rheumatic diseases |
| Q38291498 | Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases |
| Q37549888 | Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go. |
| Q58908910 | Hematopoietic stem cell transplantation for systemic lupus erythematosus |
| Q35925071 | High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study |
| Q97421314 | Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis |
| Q37311065 | Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages |
| Q38939585 | Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis |
| Q81364309 | Reconstitution of the lymphocyte compartment after lymphocyte depletion: a key issue in clinical immunology |
| Q53587160 | Recurrence of autoimmune disease after autologous peripheral blood stem cell transplantation for multiple myeloma. |
| Q37995012 | Role of mesenchymal stem cell therapy in Crohn's disease |
| Q59135921 | Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study |
| Q33424486 | Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag |
| Q92758255 | Stem Cell-Based Therapies for Multiple Sclerosis: Current Perspectives |
| Q38287103 | Stem cell autograft and allograft in autoimmune diseases |
| Q33632194 | Stem cell transplantation for autoimmune diseases |
| Q36993217 | Stem cell transplantation for rheumatic autoimmune diseases |
| Q37419051 | Stem cell transplantation in multiple sclerosis |
| Q37734210 | Stem cell transplantation in multiple sclerosis: current status and future prospects |
| Q26745715 | Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls |
| Q36976592 | Stem cells as a potential future treatment of pediatric intestinal disorders |
| Q95383104 | Stem cells: HSCT for systemic sclerosis--swallows and summers |
| Q37088891 | Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease |
| Q39440534 | The potential role of adult stem cells in the management of the rheumatic diseases. |
| Q37632215 | Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research |
| Q33803804 | Transplantation immunology: solid organ and bone marrow |
| Q33424451 | Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom? |
| Q36879678 | Update on the diagnosis and management of refractory coeliac disease |
| Q84600110 | [Hematopoietic stem cell transplantation in systemic autoimmune diseases. State of the art] |
| Q53542722 | [Pulmonary damage during polymyositis and dermatomyositis: interstitial lung disease]. |
| Q46034019 | [Stem cell therapy in multiple sclerosis: a clinical update]. |
Search more.